A study published in Neurotherapeutics dives into the role of the gut microbiome in the pathogenesis and progression of multiple sclerosis (MS), a chronic | Drug Discovery And Development ...

The following is a summary of “Circulating bile acid profiles characteristics and the potential predictive role in clear cell renal cell carcinoma progression,” published in the April 2025 issue of ...

the possible correlation between virus infections and multiple sclerosis (MS) pathogenesis is based on two main hypotheses: the 'prevalence hypothesis' and the 'poliomyelitis hypothesis'.

Three investigators and their teams have each received €100,000 funding for clinical trial development projects as part of the International Progressive MS Alliance’s Experimental Medicine Trial ...

Dr. Ashley Piper, a research microbiologist at USAMRIID, is DHA R&D-MRDC's employee of the quarter for the first quarter of ...

2 Second, scientists investigating MS pathogenesis confirmed that the natural history of MS could be altered with an immunomodulating approach, generating a rationale for the clinical use of ...

Cuprizone is a neurotoxin with copper-chelating ability, and it produces symptoms that are similar to those caused by multiple sclerosis lesions. Multiple sclerosis induced by cuprizone in animal ...

What if, rather than focusing solely on the drivers of disease (pathogenesis), we also explored the factors sustaining our ...

The COVID incubation period can range from two to 14 days. On average, it takes 3-5 days to start developing symptoms after a ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...